These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30886067)

  • 81. Diagnostic test interpretation and referral delay in patients with interstitial lung disease.
    Pritchard D; Adegunsoye A; Lafond E; Pugashetti JV; DiGeronimo R; Boctor N; Sarma N; Pan I; Strek M; Kadoch M; Chung JH; Oldham JM
    Respir Res; 2019 Nov; 20(1):253. PubMed ID: 31718645
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Elastic Registration-driven Deep Learning for Longitudinal Assessment of Systemic Sclerosis Interstitial Lung Disease at CT.
    Chassagnon G; Vakalopoulou M; Régent A; Sahasrabudhe M; Marini R; Hoang-Thi TN; Dinh-Xuan AT; Dunogué B; Mouthon L; Paragios N; Revel MP
    Radiology; 2021 Jan; 298(1):189-198. PubMed ID: 33078999
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
    Elhai M; Avouac J; Allanore Y
    Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
    Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
    Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical value of
    Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
    J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
    [No Abstract]   [Full Text] [Related]  

  • 90. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.
    Hinze AM; Lin CT; Hussien AF; Perin J; Venado A; Golden JA; Boin F; Brown RH; Wise RA; Wigley FM
    Rheumatology (Oxford); 2020 Apr; 59(4):790-798. PubMed ID: 31504916
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.
    Flechsig P; Hural O; Kreuter M; Eichhorn M; HEUßEL G; Sachpekidis C; Kauczor HU; Haberkorn U; Heussel CP; Eichinger M
    In Vivo; 2018; 32(6):1457-1462. PubMed ID: 30348701
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease.
    Aiko N; Yamakawa H; Iwasawa T; Takemura T; Okudela K; Kitamura H; Hagiwara E; Ikeda S; Baba T; Iso S; Yamaguchi Y; Kondo Y; Kurabayashi T; Ohashi K; Sato S; Ogura T
    Respir Investig; 2020 May; 58(3):196-203. PubMed ID: 32094078
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Advances in Optical Coherence Tomography and Confocal Laser Endomicroscopy in Pulmonary Diseases.
    Goorsenberg A; Kalverda KA; Annema J; Bonta P
    Respiration; 2020; 99(3):190-205. PubMed ID: 31593955
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
    Wild JM; Porter JC; Molyneaux PL; George PM; Stewart I; Allen RJ; Aul R; Baillie JK; Barratt SL; Beirne P; Bianchi SM; Blaikley JF; Brooke J; Chaudhuri N; Collier G; Denneny EK; Docherty A; Fabbri L; Gibbons MA; Gleeson FV; Gooptu B; Hall IP; Hanley NA; Heightman M; Hillman TE; Johnson SR; Jones MG; Khan F; Lawson R; Mehta P; Mitchell JA; Platé M; Poinasamy K; Quint JK; Rivera-Ortega P; Semple M; Simpson AJ; Smith D; Spears M; Spencer LG; Stanel SC; Thickett DR; Thompson AAR; Walsh SL; Weatherley ND; Weeks ME; Wootton DG; Brightling CE; Chambers RC; Ho LP; Jacob J; Piper Hanley K; Wain LV; Jenkins RG
    BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34556492
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.
    Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quantitative Imaging Metrics for the Assessment of Pulmonary Pathophysiology: An Official American Thoracic Society and Fleischner Society Joint Workshop Report.
    Hsia CCW; Bates JHT; Driehuys B; Fain SB; Goldin JG; Hoffman EA; Hogg JC; Levin DL; Lynch DA; Ochs M; Parraga G; Prisk GK; Smith BM; Tawhai M; Vidal Melo MF; Woods JC; Hopkins SR
    Ann Am Thorac Soc; 2023 Feb; 20(2):161-195. PubMed ID: 36723475
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lung MRI with hyperpolarised gases: current & future clinical perspectives.
    Stewart NJ; Smith LJ; Chan HF; Eaden JA; Rajaram S; Swift AJ; Weatherley ND; Biancardi A; Collier GJ; Hughes D; Klafkowski G; Johns CS; West N; Ugonna K; Bianchi SM; Lawson R; Sabroe I; Marshall H; Wild JM
    Br J Radiol; 2022 Apr; 95(1132):20210207. PubMed ID: 34106792
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Voxel-Wise Comparison of Co-Registered Quantitative CT and Hyperpolarised Gas Diffusion-Weighted MRI Measurements in IPF.
    Chan HF; Weatherley ND; Biancardi AM; Johns CS; Tahir BA; Karwoski RA; Bartholmai BJ; Bianchi SM; Wild JM
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066737
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.
    Averjanovaitė V; Gumbienė L; Zeleckienė I; Šileikienė V
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.